mug184 Antibody

What is mug184 Antibody and what organism does it target?

The mug184 Antibody is a rabbit polyclonal antibody that specifically targets the mug184 protein from Schizosaccharomyces pombe (strain 972/ATCC 24843), commonly known as fission yeast. This unconjugated antibody recognizes a recombinant form of the mug184 protein and has been purified using Protein A/G affinity chromatography techniques . The target protein has a UniProt accession number of O94566 and an Entrez Gene ID of 2540016 . Unlike many antibodies that target mammalian proteins, mug184 Antibody is specifically developed for research involving yeast biological systems, making it a specialized tool for fungal biology researchers.

What applications has mug184 Antibody been validated for?

The mug184 Antibody has been validated for two primary applications: Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blotting (WB) . For ELISA applications, the antibody can be used to detect native or recombinant mug184 protein in solution or immobilized on plates. In Western blotting applications, the antibody can recognize denatured mug184 protein separated by SDS-PAGE and transferred to membranes. When designing experiments, researchers should note that while many antibodies undergo extensive cross-application validation, the current validation data for mug184 Antibody specifically confirms its reliability in these two methodologies. For experimental planning, it is advisable to perform preliminary validation if using this antibody in other immunological techniques such as immunoprecipitation or immunofluorescence.

How should mug184 Antibody be stored and handled for optimal results?

For long-term storage, mug184 Antibody should be maintained at either -20°C or -80°C to preserve its immunoreactivity and specificity . When shipping is required, the antibody should be transported on blue ice to maintain cold chain integrity . For routine laboratory use, it is recommended to aliquot the antibody into single-use volumes upon first thawing to avoid repeated freeze-thaw cycles, which can degrade antibody performance. Each aliquot should be sufficient for a single experiment to maintain optimal antibody performance. Additionally, before use, the antibody should be gently mixed by inversion rather than vortexing, which can cause protein denaturation and aggregation that may compromise binding specificity. For working solutions, dilution in appropriate buffers (typically PBS with 0.1% BSA or similar carrier protein) can help stabilize the antibody during experimental procedures.

What components are supplied with the mug184 Antibody product?

The mug184 Antibody product typically includes three key components that enhance its research utility: 1) 200μg of recombinant immunogen protein/peptide that serves as a positive control for validation experiments; 2) 1ml of pre-immune serum that can be used as a negative control to assess non-specific binding; and 3) The rabbit polyclonal antibody itself, purified by Protein A/G affinity chromatography . This comprehensive package provides researchers with the necessary tools to establish proper control conditions in their experiments. The inclusion of both positive and negative controls is particularly valuable for researchers working with novel experimental systems or optimizing detection protocols, as these controls can help distinguish specific signal from background or non-specific interactions.

How can I optimize Western blot protocols using mug184 Antibody?

Optimizing Western blot protocols with mug184 Antibody requires careful consideration of several parameters. First, determine the optimal antibody dilution through a titration experiment, typically starting with a range of 1:500 to 1:2000 for primary antibody incubation. Second, adjust blocking conditions to minimize background—for yeast proteins, a blocking solution of 5% non-fat dry milk in TBST often yields better results than BSA-based blockers. Third, optimize incubation times and temperatures; overnight incubation at 4°C often produces cleaner results than shorter incubations at room temperature. For enhancing detection of low-abundance mug184 protein, consider using enhanced chemiluminescence (ECL) substrates with higher sensitivity or signal amplification systems.

When troubleshooting inconsistent results, examine sample preparation methods first. Yeast cells have tough cell walls requiring effective lysis methods—using glass beads or enzymatic approaches with zymolyase can improve protein extraction efficiency. Additionally, include phosphatase and protease inhibitors in lysis buffers to prevent degradation of target proteins. If non-specific bands appear, increasing the stringency of wash steps (using higher salt concentrations or adding 0.1% SDS to wash buffers) may help reduce background signals while maintaining specific binding to the mug184 protein.

What are the cross-reactivity considerations when using mug184 Antibody?

Understanding cross-reactivity is crucial when working with mug184 Antibody across different experimental systems. The antibody has been specifically developed against Schizosaccharomyces pombe mug184 protein , but possible cross-reactivity with proteins from closely related species should be carefully evaluated. While the antibody is reported to be yeast-reactive , researchers working with other yeast species like Saccharomyces cerevisiae or Candida albicans should conduct preliminary validation experiments to assess potential cross-reactivity with homologous proteins.

For cross-reactivity assessment, perform comparative Western blots using protein extracts from multiple yeast species alongside S. pombe as a positive control. Sequence alignment analysis of the mug184 protein region used as immunogen against potential homologs in other species can provide theoretical predictions of cross-reactivity. When working with complex samples containing both yeast and non-yeast components, additional controls may be necessary to confirm signal specificity. This is especially important in studies involving mixed microbial communities or host-pathogen interaction models where multiple species are present simultaneously.

How can I validate the specificity of mug184 Antibody in my experimental system?

Validating antibody specificity is essential for generating reliable research data. For mug184 Antibody, a multi-faceted validation approach is recommended. First, perform a knockout/knockdown validation by comparing antibody reactivity in wild-type S. pombe versus mug184-deleted or mug184-depleted strains. The absence or significant reduction of signal in the knockout/knockdown samples strongly supports antibody specificity. Second, conduct a peptide competition assay by pre-incubating the antibody with excess immunizing peptide before application to your samples—specific signals should be blocked by this pre-treatment.

Third, verify molecular weight correspondence by ensuring that the detected protein band aligns with the predicted molecular weight of mug184 protein. Fourth, if possible, use orthogonal detection methods such as mass spectrometry to confirm the identity of the immunoprecipitated protein. Finally, testing the antibody across multiple applications (e.g., both Western blot and ELISA) and observing consistent results provides additional confidence in specificity. The supplied recombinant immunogen protein included with the antibody package serves as an excellent positive control for these validation experiments.

What are the recommended controls when using mug184 Antibody in Schizosaccharomyces pombe research?

When designing experiments with mug184 Antibody in S. pombe research, implementing proper controls is crucial for reliable interpretation of results. Primary controls should include: 1) A negative control using the pre-immune serum provided with the antibody kit to establish baseline non-specific binding; 2) A positive control using the supplied recombinant immunogen protein to confirm antibody functionality; 3) A technical control involving wild-type S. pombe extract to establish normal expression patterns and localization; and 4) A biological control using mug184 deletion or knockdown strains to verify signal specificity.

Additional specialized controls may include: 1) Epitope-tagged mug184 protein expressed in S. pombe to provide a reference signal with known specificity; 2) Time-course samples if studying cell-cycle-dependent expression of mug184; and 3) Subcellular fractionation controls if investigating protein localization. For quantitative applications, standard curves using purified recombinant mug184 at known concentrations can serve as calibration controls. Together, these controls create a robust framework for experimental design that enhances data reliability and facilitates accurate interpretation of results in mug184-focused research.

How does the polyclonal nature of mug184 Antibody affect experimental design?

The polyclonal nature of mug184 Antibody carries important implications for experimental design and data interpretation. Unlike monoclonal antibodies that recognize a single epitope, polyclonal antibodies like mug184 Antibody contain a heterogeneous mixture of immunoglobulins recognizing multiple epitopes on the target protein . This characteristic offers both advantages and challenges that researchers must consider when planning experiments.

What considerations should be made when using mug184 Antibody for co-immunoprecipitation experiments?

When planning co-immunoprecipitation (Co-IP) experiments with mug184 Antibody, several technical considerations can optimize success. First, while the antibody is validated for Western blot and ELISA applications , preliminary testing for IP efficiency is recommended using various antibody-to-lysate ratios (typically 1-10 μg antibody per 100-500 μg total protein). Second, lysis buffer composition significantly impacts results—for yeast samples, buffers containing 1% NP-40 or Triton X-100 with 150 mM NaCl often preserve protein-protein interactions while enabling effective extraction.

Third, consider crosslinking approaches such as formaldehyde or DSP (dithiobis[succinimidyl propionate]) treatment before lysis to stabilize transient or weak interactions. Fourth, pre-clearing lysates with Protein A/G beads can reduce non-specific binding. Fifth, incorporate appropriate controls including: IgG isotype control to identify non-specific interactions; "bead-only" controls to detect proteins binding to the support matrix; and when possible, samples from mug184-knockout strains to confirm specificity. Finally, consider performing reciprocal Co-IPs (using antibodies against suspected interaction partners to pull down mug184) to strengthen evidence for specific interactions. These methodological refinements can substantially improve the specificity and reproducibility of Co-IP experiments involving mug184 protein.

How can I incorporate mug184 Antibody into multiplex immunoassays?

Integrating mug184 Antibody into multiplex immunoassays requires careful optimization to ensure compatibility with other detection reagents. First, evaluate potential fluorophore or enzyme conjugation options—direct conjugation to fluorophores like Alexa Fluor or enzymes such as HRP using commercial antibody labeling kits can maintain binding activity while enabling multiplex detection. Alternatively, use spectrally distinct secondary antibodies raised against rabbit IgG to detect mug184 Antibody while using primaries from different host species for other targets.

For bead-based multiplexing platforms, consider biotinylating mug184 Antibody for coupling to streptavidin-coated beads with unique spectral or size characteristics. When designing panel combinations, perform sequential titrations of each antibody individually before combining them to determine optimal working concentrations that provide specific signal with minimal background. Cross-reactivity testing between all components is essential—test each primary antibody against all secondary antibodies to ensure specificity. Additionally, include compensation controls when using multiple fluorophores to correct for spectral overlap. For quantitative multiplex assays, develop standard curves using the recombinant immunogen protein provided with mug184 Antibody to enable accurate quantification across a dynamic range of target concentrations.

What approaches can enhance detection sensitivity when working with low-abundance mug184 protein?

Enhancing detection sensitivity for low-abundance mug184 protein requires implementing several advanced techniques. For Western blotting applications, consider signal amplification systems such as tyramide signal amplification (TSA), which can increase sensitivity by 10-100 fold over conventional detection methods. Using high-sensitivity chemiluminescent substrates specifically designed for detecting low-abundance proteins can also significantly improve signal detection. Additionally, optimizing transfer conditions with lower methanol concentrations and longer transfer times can enhance protein transfer efficiency from gel to membrane, particularly for hydrophobic or high molecular weight proteins.

For immunoprecipitation-based enrichment before detection, increasing the starting material volume and extending antibody incubation time (overnight at 4°C) can improve capture of low-abundance targets. When performing ELISA, consider using amplification steps such as poly-HRP systems or implementing more sensitive detection methods like electrochemiluminescence (ECL). Sample preparation techniques also play a crucial role—using fractionation approaches to isolate specific cellular compartments where mug184 may be concentrated can effectively increase local protein concentration. Finally, reducing non-specific binding through optimized blocking (using casein-based blockers rather than BSA for certain applications) and incorporating longer, more stringent wash steps can dramatically improve signal-to-noise ratio, making detection of low-abundance mug184 protein possible.

How can I adapt protocols for time-course studies of mug184 expression during cell cycle progression?

Designing time-course studies to monitor mug184 expression during cell cycle progression requires specialized adaptations to standard protocols. First, establish reliable cell synchronization methods for S. pombe—nitrogen starvation followed by release, hydroxyurea block-release, or cdc25-22 temperature-sensitive mutants at restrictive temperature followed by release are effective approaches. Second, develop a consistent sampling strategy with appropriate time intervals (typically 15-20 minute intervals for S. pombe with ~2.5-3 hour cell cycle).

Third, implement rapid sample processing to preserve cell cycle state—flash freezing in liquid nitrogen followed by mechanical disruption with pre-chilled equipment minimizes protein degradation and modification changes during processing. Fourth, include parallel samples for confirming cell cycle progression using flow cytometry or microscopy with DNA staining. For Western blot analysis, loading equal cell numbers rather than equal protein amounts may better represent the per-cell expression levels across different cell cycle stages. Include known cell cycle-regulated proteins (e.g., Cdc13, Cdc2) as comparative controls alongside mug184 detection. For quantitative analysis, normalize mug184 signals to a stably expressed reference protein rather than total protein loading, as the latter may vary throughout the cell cycle. These methodological adaptations enable accurate tracking of mug184 expression dynamics during cell cycle progression.

Future Directions in mug184 Research Methodology

As research technologies continue to evolve, several emerging methodologies hold promise for advancing mug184 research beyond current capabilities. Super-resolution microscopy techniques such as STORM or PALM could enable visualization of mug184 protein localization at unprecedented nanoscale resolution in fixed samples. Development of genetically encoded tags compatible with S. pombe that maintain mug184 function would facilitate live-cell imaging studies. Advances in mass spectrometry-based proteomics approaches could enable more comprehensive mapping of mug184 interaction networks and post-translational modifications.